Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
Share
0 Min Read
SHARE
Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.
